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CD4+ helper T cells are traditionally classified as
Th1 and Th2 cells. Other subclasses of helper T cells
were later discovered and named regulatory T cells
(Tregs) and interleukin-17 (IL-17) producing T
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cells (Th17 cells)1). The pro-inflammatory characte-
ristics of the IL-17 cytokine are well documented2);
however, the role and importance of Th17 cells have
only recently been discovered3, 4).
The differentiation of Th17 cells from naïve T cell
populations is initiated by the co-stimulation of IL-6
and transforming growth factor- (TGF- ). Smadβ β
and STAT3 pathways, respectively, are used as
signal transduction molecules and also eventually
activate retinoic acid related orphan receptors tγ
(ROR t). Th1 and Th2 cells inhibit this processγ
through interferon- (IFN- ) and IL-4γ γ 5).
Diseases associated with T cell-mediated injury
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Purpose: Interleukin-17-producing T cell (Th17 cell) is a newly discovered subtype of helper T cell. Its
function and importance in the pathogenesis of a broad range of immune diseases are under active
investigation. However, little is currently known about the role of Th17 cells in ischemia-reperfusion
(IR) injury of the kidney, a common pathophysiologic occurrence in various renal disease processes.
Methods: We measured the number of infiltrated T lymphocytes and Th17 cells in C57Bl/6 mouse
kidneys in sham-operated controls and following varying degrees of renal IR injury induced by renal
pedicle clamping and reperfusion. The cell count results were compared to accompanying histologic
damage and serum creatinine levels after 35 min and 45 min of ischemia, and following reperfusion
of 48, 72, 96, and 168 hrs.
Results: The number of T lymphocytes increased as ischemia time increased. However, the number
of Th17 cells was not significantly affected by prolonged ischemia and reperfusion. Furthermore, the
degree of histologic damage and serum creatinine levels did not correlate with the T lymphocyte and
Th17 cell count numbers.
Conclusion: We did not observe any evidence that Th17 cells are directly linked to renal tissue damage
caused by IR injury. The role and importance of helper T cells in renal IR injury need to be evaluated
further in the light of the interaction with Th1, Th2, and regulatory T cells rather than Th17 alone.
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have previously been explained by the balance between
Th1 and Th2 cells. However, after Th17 cell involve-
ment was reported in experimental autoimmune en-
cephalomyelitis6), it was recommended that Tregs and
Th17 cells should also be included in the explanation
model of T cell-mediated injury.
Interleukin-17 produced by Th17 cells is a pro-
inflammatory cytokine that induces neutrophil mobili-
zation and differentiation7) and T cell activation
8, 9).
However, functional studies on Th17 cells in specific
organs and diseases have been inadequate and require
further investigation. The relationship between Th17
cells and renal disease processes has mainly been
concentrated on the study of kidney allograft rejection.
It was suggested that IL-17 plays an important role
in the early stages of allograft rejection by producing
pro-inflammatory cytokines10). In addition, Th17 cells
also contribute to lymphoid neo-genesis in chronic
rejection, thus deteriorating the clinical course11).
Ischemia-reperfusion (IR) injury of the kidney is
a crucial pathophysiologic mechanism involved in acute
renal failure and adverse drug reactions including
cyclosporine toxicity as well as in allograft rejection.
The infiltration of neutrophils and macrophages, acti-
vation of C5a and membrane attack complex, and
activation of various cytokines have been thought to
be involved in this type of injury. Recently, it was
also revealed that T lymphocytes play a key role in
IR injuries12, 13).
In this study, we used kidney ischemia-reperfusion
injury in a mouse model to evaluate whether Th17
cells are responsible for the initiation and progression
of this type of injury.
MATERIALS AND METHODS
1. Animals and experiments
All experiments were performed on 8-week-old
male C57Bl/6 mice (Damul Science, Dajeon, Korea)
weighing 25-26 g. They were provided standard
laboratory diet and water and cared under a protocol
approved by the Institutional Animal Care and Use
Committee of the Chungnam National University
Medical School. We divided the mice into 3 groups:
sham-operated mice (n=16, sacrificed 48hr, 72hr,
96hr, and 168hr post-operatively), 35 min ischemia
reperfusion mice (n=14, sacrificed 48hr, 72hr, 96hr,
and 168hr post-operatively), and 45 min ischemia
reperfusion mice (n=14, sacrificed 48hr, 72hr, 96hr,
and 168hr post-operatively). IR injury was induced
by reperfusion after clamping (35 minutes and 45
minutes) both the renal artery and vein. Mice were
anesthetized by IP injection (2.2 l/g) with a mixtureµ
of ketamine (100 g/g, Ketalarµ Ⓡ; Bayer, Leverkusen,
Germany) and xylazine (46 g/g, Rompunµ Ⓡ; Bayer).
2. Renal function
To evaluate renal function, blood was obtained via
the inferior vena cava when the mice were sacrificed.
Serum creatinine levels were evaluated using a To-
shiba 200FR chemistry autoanalyzer (Toshiba Medical
Systems Co., Tokyo, Japan).
3. Tissue preparation and light microscopy
Kidneys were excised immediately after sacrifice.
One piece of the left kidney was fixed in 10% buffered
formaldehyde at room temperature and then embedded
in Paraplast (Sherwood Medical, St. Louis, MO, USA)
for later histologic evaluation. Tissue sections (4 m)μ
were mounted on glass slides and stained with pe-
riodic acid-Schiff (PAS). Histologic grading of IR
injury was performed as previously described14) by
one of the authors (Lim). Five serial fields along the
outer medulla area were viewed under 400 magnifi× -
cation. Necrosis, vacuolar change, and desquamation
of tubular epithelial cells were regarded as histologic
parameters of tubular damage, and the number of tu-
bules showing damage in more than 50% of the epi-
thelial cells was counted in each case.
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4. Immunohistochemistry
Embedded tissues were cut serially (4 m) andμ
stained by an avidin-biotin complex method as pre-
viously described15). After deparaffinization and rehy-
dration, antigen retrieval was performed using a
microwave oven (2 5 min in citrate buffer, pH 6.0).×
A 0.3% H2O2 solution was used to block endogenous
peroxidase activity. Primary antibodies, dilution, reac-
tion time and temperature were as follows: CD3 (anti-
mouse rabbit monoclonal, Lab Vision, Fremont Blvd.,
Fremont, CA, USA, 1:200, 2hr at room temperature)
and IL-17 (anti-mouse rabbit polyclonal, Santa Cruz
Biotechnology, CA, USA, 1:300, 2hr at room tempera-
ture). The number of cells exhibiting positive results
with the above antibodies was counted in 5 serial high
power fields (HPF) along the outer medulla area under
400 magnification.×
5. Statistical analysis
Data are presented as mean standard deviation.±
Comparison between the groups was performed using
the Kruskal-Wallis test or Mann-Whitney U test.
RESULTS
1. Histologic grading of IR injury and its
relationship to serum creatinine levels
The sham-operated control group showed no evi-
dence of renal damage. The 35 min IR group (n=14)
showed tubular damage in 9.7 3.2% of the tubules±
compared to 13.8 4.2% in the 45 min IR group (n=±
14) and was statistically significant (p=0.003). The
average serum creatinine level was also higher in the
45 min ischemia group (0.40 0.18 mg/dL in the 35±
min ischemia group vs. 0.90 0.56 mg/dL in the 45±
min ischemia group, and 0.20 0.03 mg/dL in the±
sham-operated group, p<0.01). The peak serum
creatinine level was observed at 48hr reperfusion
time in both 35 min and 45 min ischemia groups
(Fig. 1).
The extent of tubular damage was not proportional
to reperfusion times in both the 35 min and 45 min
ischemia groups. In the 35 min ischemia group, the
percentage of tubular damage was not significantly
affected by reperfusion times (11.6 4.4% at 48hr±
reperfusion time, 7.2 2.4% at 72hr, 8.2 1.3% at± ±
96hr and 11.5 1.9% at 168 hr, p=0.113). In the 45±
min ischemia group, tubular damage was observed in
13.6 3.4% of the tubules at 48hr reperfusion time,±
15.3 3.1% at 72hr, 11.3 0.6% at 96hr and 15.7 8.1± ± ±
% at 168hr (p=0.349, Fig. 2).
2. Infiltration of T lymphocytes and Th17 cells
CD3-positive T lymphocytes were rarely observed
(1.1 1.1/5HPF) and IL-17-positive Th17 cells were±
not observed in the kidneys of sham- operated mice.
The number of T lymphocytes was not significantly
different in the 35 min and 45 min ischemia groups
(15.2 5.0/5HPF in 35 min vs. 15.4 2.9/5HPF in 45± ±
min group, p=0.635). T lymphocyte infiltration was
generally increased by the reperfusion time in the 35
min ischemia group (13.0 3.8/5HPF at 48hr, 10.7± ±
2.3 at 72hr, 17.5 4.4 at 96hr, and 19.7 4.7 at 168hr,± ±
Fig. 1. Serum creatinine level. The average serum crea-
tinine level was higher in the 45 min ischemia
group (45 min IR) than in the 35 min ischemia
group (35 min IR) or sham-operated mice (S).
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p=0.047), however, there was no difference in the
number of T lymphocytes in the 45 min ischemia
group by the reperfusion times (16.3 1.7/5HPF at±
48hr, 16.3 4.0 at 72hr, 16.3 2.2 at 96hr, and 12.0± ± ±
2.0 at 168hr, p=0.858).
The number of Th17 cells was similar in the 35
min and 45 min ischemia groups (2.8 1.3/5HPF in±
35 min vs. 2.7 0.7/5HPF in 45 min group, p=0.982).±
The reperfusion times did not significantly affect the
infiltration of Th17 cells in either group (1.5 0.6/5±
HPF at 48hr, 3.0 1.7 at 72hr, 3.3 1.0 at 96hr, and± ±
3.7 0.6 at 168hr in the 35 min ischemia group, p=±
0.079 and 2.5 0.6/5HPF at 48hr, 2.3 0.6 at 72hr,± ±
3.0 0.8 at 96hr, and 3.0 1.0 at 168hr in the 45 min± ±
ischemia group, p=0.561, Fig. 3). The ratio of the
number of Th17 cells to the number of CD3-positive
T cells was similar in the 35 min and 45 min ischemia
groups (0.19 0.09 in 35 min vs. 0.18 0.06 in 45 min,± ±
p=0.839). This ratio did not show significant change
by the reperfusion times (0.13 0.084 at 48hr, 0.28± ±
0.13 at 72hr, 0.20 0.079 at 96hr, and 0.19 0.050 at± ±
168hr in the 35 min ischemia group, p=0.296 and
0.16 0.048 at 48hr, 0.15 0.042 at 72hr, 0.19 0.057± ± ±
at 96hr, and 0.25 0.043 at 168hr in the 45 min±
ischemia group, p=0.114).
DISCUSSION
IR injury denotes the occurrence of tissue damage
when blood supply returns to tissue after a period of
ischemia. Although it is clear that the immune system
is involved in IR injury of the kidney16, 17), there is
more to be investigated on the effector cells and the
roles they play. The cellular components primarily
associated with IR injury are those of the innate im-
mune system such as neutrophils and macrophages.
In this study, however, we evaluated the number of
infiltrated T lymphocytes as there is growing evidence
that adaptive immunity is also involved in IR injury18).
As mentioned above, Th17 cell is a newly discovered
subtype of T lymphocyte and our knowledge about its
function and association with diseases is still expanding.
Some investigators have presented evidence supporting
Th17 cell involvement in renal IR injury. Tadagavadi
et al. reported indirect evidence of this by showing
that netrin-1, a neuronal guidance molecule, has a
protective effect against renal IR injury through the
inhibition of cytokines associated with the activation
of Th1/Th2/Th17 cells19). Li et al. demonstrated that
IL-17 plays an important role in the acute phase of
renal IR injury as a component of innate immunity;
Fig. 2. Tubular damage after IR injury. Tubular epithelial
cells showed necrosis, vacuolar change, and des-
quamation (A, PAS, original magnification 200).×
The 45 min ischemia group showed more severe
damage than 35 min ischemia group. However, the
extent of tubular damage was not proportional to
reperfusion times in both the 35 min and 45 min
ischemia groups (B).
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however, this interleukin was produced by infiltrating
neutrophils, not by Th17 cells20). Therefore, clear and
direct evidence of Th17 cell involvement in renal IR
injury has not yet been reported.
Based on our observations, the major determinant
of the degree of tubular damage and serum creatinine
levels was ischemia time rather than reperfusion time.
The number of T lymphocytes and Th17 cells and the
ratio were not affected by the length of ischemia time,
and T lymphocyte number alone was increased by the
prolongation of reperfusion in the 35 min ischemia
group. These results imply that the influence of T
lymphocytes resulting in histologic damage during IR
injury is not greater than those of other established
contributing components such as neutrophils21) or the
complement system22). The role of lymphocytes in IR
injury18) has recently been studied using CD4 and/or
CD8 T cell-deficient mice. In these studies, histologic
and serologic damage was ameliorated in CD4-defi-
cient mice, while CD8-deficient mice showed similar
damage as in the wild type mice. These results imply
that helper T cells play a critical role in renal IR injury.
Fig. 3. CD3-positive T cell and Th17 cell infiltration after IR injury.
Immunohistochemistry for CD3 and IL-17 revealed infiltration
of T lymphocytes and Th17 cells (A, 400). The number of T×
lymphocytes was not significantly different in the 35 min and
45 min ischemia groups, and generally increased by the reper-
fusion time in the 35 min ischemia group. The number of Th17
cells was similar in the 35 min and 45 min ischemia groups. The
reperfusion times did not significantly affect the infiltration of
Th17 cells in either group. The ratio of Th17 cells and T lym-
phocytes showed similar pattern (B).
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We also observed that while prolonged reperfusion
times increased T cell infiltration, Th17 cells were
not a major component of these infiltrates. Further-
more, histologic damage and serologic results were
solely based on ischemia time, not T cell or Th17
cell infiltration.
In conclusion, we did not observe any evidence that
Th17 cells are directly associated with renal tissue
damage by IR injury. This study has some limitations,
and the most important one is that quantitative and
functional analysis of IL-17 was not performed. We
only counted the number of infiltrating cells along the
outer medulla and this method was used in our pre-
vious studies14, 23). However, we found limitations in
employing this method as it neglected the cells in the
inner medulla and cortex despite the small number of
overall infiltrating cells. Although there are limitations
as mentioned above in this study, it is reasonable to
conclude that the role and importance of helper T
cells in renal IR injury need to be further studied in
the light of the interaction with Th1, Th2, and Tregs
rather than Th17 alone.
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